PTEN and glioblastoma: In fact use of rapamycin in a small clinical trial with 15 recurrent glioblastoma patients lacking PTEN expression showed increased phosphorylation of Akt at Ser-473 in 50% of the patients, indicating the importance of relief of the negative feed back loop in vivo[109].